• No results found

Innovative Approaches to Patient-centered Care and Research in Interstitial Lung Disease

N/A
N/A
Protected

Academic year: 2021

Share "Innovative Approaches to Patient-centered Care and Research in Interstitial Lung Disease"

Copied!
11
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

[00546]

Omslag:Karen Moor

FC Formaat: 170 x 240 mmRugdikte: 16,8 mm Boekenlegger: 60 x 230 mmDatum: 22-06-2020

Uitnodiging

Voor het bijwonen van de openbare

verdediging van het proefschrift

Innovative approaches to

patient-centered care

and research in

interstitial lung disease

door

Karen Moor

Dinsdag 15 september 2020

om 13:30 uur

Locatie

Professor Andries Queridozaal Onderwijscentrum Erasmus Medisch Centrum

Dr. Molewaterplein 40 Rotterdam

Na afl oop bent u van harte welkom op de receptie ter plaatse

Paranimfen

Joost Kuipers Jente Klok Karen Kuipers-Moor Duyststraat 59 3023 EC Rotterdam c.moor@erasmusmc.nl

Interstitial lung diseases (ILDs) are a

large, heterogeneous group of more

than 200 diseases, that diffusely affect

the lungs. This thesis primarily focuses

on (idiopathic) pulmonary fibrosis and

sarcoidosis. ILDs often have a major

impact on quality of life, due to

symp-toms as dyspnea, cough, and fatigue.

The first aim of this thesis was to

evaluate gaps in care, unmet needs,

patient perspectives, and patient

experiences with the care pathway.

These insights are highly needed to

facilitate a patient-centered approach

to care and research in ILD.

The second part of this thesis describes

the development and evaluation of

eHealth solutions, aimed at improving

health outcomes, optimizing quality of

life, and enabling personalized

treat-ment for patients with ILD.

Karen Moor

Innovative approaches to

patient-centered care and

research in interstitial

lung disease

K

ar

en Moor

Inn

ov

ati

ve app

roaches to p

atie

n

t-ce

n

te

red ca

re and

resea

rch in i

n

(2)
(3)

Innovative Approaches to Patient-centered Care and

Research in Interstitial Lung Disease

(4)

The work described in this thesis was conducted at the Department of Respiratory Medicine, Erasmus MC, Rotterdam, the Netherlands.

Innovative approaches to patient-centered care and research in interstitial lung disease ISBN: 978-94-6361-437-5

Unrestricted grants for research described in this thesis have been received from: The Netherlands Organization for Health Research and Development (ZonMw), Erasmus MC Thorax Foundation, Hoffman la Roche, and Boehringer Ingelheim.

Lay out and printing: Optima Grafische Communicatie, Rotterdam, the Netherlands (www.ogc.nl)

Cover design and copy right holder: Jente Klok (www.jenteklok.com)

All rights reserved. No part of this thesis may be reproduced, stored in a retrieval system of any nature, or transmitted in any form or by any means, without permission of the author, or when appropriate, the publishers of the publications.

(5)

Innovative Approaches to Patient-centered Care and

Research in Interstitial Lung Disease

Innovaties in patiëntgerichte zorg en

onderzoek in interstitiële longziekten

Proefschrift

ter verkrijging van de graad van doctor aan de Erasmus Universiteit Rotterdam

op gezag van de rector magnificus Prof.dr. R.C.M.E. Engels

en volgens besluit van het College voor Promoties. De openbare verdediging zal plaatsvinden op

dinsdag 15 september 2020 om 13:30 uur

door

Catharina Christina Moor

(6)

PROMOTIECOMMISSIE

Promotor Prof. dr. J.G.J.V. Aerts

Overige leden Prof. dr. V. Cottin Prof. dr. M. Kreuter

Prof. dr. S.C.E. Klein Nagelvoort - Schuit

(7)

TAbLE Of COnTEnTS

PART 1 InTRODuCTIOn

General introduction

Chapter 1 Comprehensive care of interstitial lung disease

Published as book chapter in Encyclopedia of Respiratory Medicine

Chapter 2 Comprehensive care for patients with sarcoidosis

J. Clin. Med. 2020, 9(2), 390.

PART 2 GAPS In CARE In InTERSTITIAL LunG DISEASE

Chapter 3 Gaps in care of patients living with pulmonary fibrosis: a joint pa-tient and expert statement on the results of a Europe-wide survey

ERJ Open Res. 2019 Oct 21;5(4):00124-2019.

Chapter 4 Integrating patient perspectives into personalized medicine in Idiopathic Pulmonary Fibrosis

Front Med. 2017 Dec 20;4:226.

Chapter 5 Patient expectations, experiences and satisfaction with nintedanib and pirfenidone in idiopathic pulmonary fibrosis: a quantitative study

Respir Res. 2020: in press

Chapter 6 Needs, Perceptions and Education in Sarcoidosis: A Live Interactive Survey of Patients and Partners

Lung 2018; 196(5): 569–575

Chapter 7 Managing fatigue in patients with interstitial lung disease

Chest 2020 May 6;S0012-3692(20)30873-4 11 25 55 79 111 133 149 165

(8)

PART 3 DEvELOPMEnT AnD EvALuATIOn Of EHEALTH SOLuTIOnS In InTERSTITIAL LunG DISEASE

Chapter 8 Development and feasibility of an eHealth tool for idiopathic pul-monary fibrosis

Eur Respir J. 2018; Mar 29;51(3):1702508.

Chapter 9 A home monitoring program including real-time wireless home spirometry in idiopathic pulmonary fibrosis: a pilot study on expe-riences and barriers

Respir Res. 2018, May 29;19(1):105.

Chapter 10 Feasibility of a comprehensive home monitoring program for

sarcoidosis

J Pers Med. 2019 May 5;9(2):23.

Chapter 11 Diurnal variation in forced vital capacity in patients with fibrotic

interstitial lung disease using home spirometry

ERJ Open Res. 2020 Jan; 6(1): 00054-2020.

Chapter 12 Home monitoring in patients with idiopathic pulmonary fibrosis: a

randomized controlled trial

Am J Respir Crit Care Med. 2020 Apr 23.

Chapter 13 Exhaled breath analysis by use of eNose technology: a novel

diag-nostic tool for interstitial lung disease

Eur Respir J. 2020: in press

PART 4 DISCuSSIOn

Chapter 14 General discussion Summary

Samenvatting PhD portfolio List of publications About the author Dankwoord 183 191 201 219 229 255 255 304 312 320 324 328 330

(9)
(10)
(11)

Introduction

Referenties

GERELATEERDE DOCUMENTEN

It is thus important for national parks across South Africa and globally to identify their distinct park specific attributes, products and services that could

The ACT study described in this thesis was financially supported by the Netherlands Organization for Health Research and Development (ZonMW): Dutch National Care for the

The studies described in this thesis were financially supported by Foundation Fighting Blindness, The Netherlands Organisation for Health Research and Development: ZonMw,

JHU received two grants of ZonMw, a Dutch organization for Health Research and development for 1) The HysNiche trial: Hysteroscopic resection of uterine caesarean scar

The study was funded by ZonMw (the Netherlands Organization for Health Research and Development) in the context of the research program Pregnancy and Childbirth. This

The Netherlands Organization for Health, Research and Development: ZonMw (Zorg Onderzoek Nederland) funded the research described in this thesis. Astra Zeneca, Ferring

The randomised controlled trial presented in this thesis was funded by a grant from the Netherlands Organisation for Health Research and Development (ZonMw) health care

The aim of this study was thus to investigate the pedigree structure, inbreeding levels, generation interval, effective population size and founder contributions